Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1995 1
2002 1
2004 1
2006 4
2007 5
2015 1
2018 2
2021 8
2022 31
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G; Gruppo Oncologico Nord Ovest. Falcone A, et al. Among authors: picone v. J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928. J Clin Oncol. 2007. PMID: 17470860 Clinical Trial.
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Carconi C, Cerreti M, Roberto M, Arrivi G, D'Ambrosio G, De Felice F, Di Civita MA, Iafrate F, Lucatelli P, Magliocca FM, Picchetto A, Picone V, Catalano C, Cortesi E, Tombolini V, Mazzuca F, Tomao S. Carconi C, et al. Among authors: picone v. Crit Rev Oncol Hematol. 2023 Jun;186:103990. doi: 10.1016/j.critrevonc.2023.103990. Epub 2023 Apr 13. Crit Rev Oncol Hematol. 2023. PMID: 37061075 Review.
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, Neri I, Ortoncelli M, Schena D, Stingeni L, Hansel K, Piccolo V, Di Brizzi V, Potenza C, Tolino E, Bianchi L, Manti S, De Pasquale R, Di Lernia V, Caminiti L, Galli E, Coppo P, Chiricozzi A, De Simone C, Guerriero C, Amoruso FG, Provenzano E, Leonardi S, Licari A, Marseglia GL, Palermo A, Di Pillo S, Russo D, Moschese V, Patella V, Peduto T, Ferreli C, Zangari P, Veronese F, Berti SF, Gruber M, Pezzolo E, Termine S, Satta R, Dragoni F, Esposito M, Fargnoli MC, Chiodini P, Vallone Y, di Vico F, Picone V, Napolitano M. Patruno C, et al. Among authors: picone v. J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602. J Dermatolog Treat. 2023. PMID: 37580895 Free article.
Vitiligo during dupilumab therapy.
Picone V, Napolitano M, Torta G, Fabbrocini G, Patruno C. Picone V, et al. JAAD Case Rep. 2023 Apr 26;36:51-53. doi: 10.1016/j.jdcr.2023.03.025. eCollection 2023 Jun. JAAD Case Rep. 2023. PMID: 37250007 Free PMC article. No abstract available.
Chondroid syringoma: an asymptomatic benign tumor.
Martora F, Mascolo M, Fabbrocini G, Annunziata A, Picone V, DE Fata Salvadores G, Russo D, Marasca C. Martora F, et al. Among authors: picone v. Ital J Dermatol Venerol. 2022 Oct;157(5):450-452. doi: 10.23736/S2784-8671.22.07191-2. Epub 2022 Mar 11. Ital J Dermatol Venerol. 2022. PMID: 35274880 No abstract available.
70 results